
Bharat Parenterals Ltd. (BPLPHARMA) Share Price Rises 8.28% Today
Updated: 25 Sept 2026 • 10:28 am
Posted by:

Bharat Parenterals Share Price moved higher today, with the stock at Rs 1,710, up 8.28% from the previous close of Rs 1,579.25. The company’s market capitalisation stands at Rs 1,059.26 crore, while turnover was Rs 0.13 crore. The data confirms a clear price rise in Bharat Parenterals Share Price Today, but it does not establish a company-specific catalyst. For readers tracking Bharat Parenterals Stock News, the move matters because it places the name among Stocks in News in the Indian Stock Market on a day when the broader Share Market Today is watching fresh price action in healthcare names. Univest is tracking the event with verified market data and sector context, so investors can read the move alongside valuation, fundamentals and peer comparison before drawing conclusions.
Bharat Parenterals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,710 |
| Previous Close | Rs 1,579.25 |
| Today's Move | Rs 130.75 (+8.28%) |
| Open | Rs 1,600 |
| High | Rs 1,745.95 |
| Low | Rs 1,590.05 |
| Turnover | Rs 0.13 crore |
| Market Capitalisation | Rs 1,059.26 crore |
| Market Cap Category | Small Cap |
Bharat Parenterals Ltd. (BPLPHARMA) rose to Rs 1,710 from the previous close of Rs 1,579.25, a move of Rs 130.75 or 8.28%. The stock opened at Rs 1,600, reached a high of Rs 1,745.95, recorded a low of Rs 1,590.05.
The stock opened at Rs 1,600, touched an intraday high of Rs 1,745.95 and a low of Rs 1,590.05, before closing at Rs 1,710. The day’s gain of Rs 130.75 shows Bharat Parenterals Share Price holding above the previous close by 8.28%. In today’s stock news flow, that places Bharat Parenterals among top movers in healthcare on a percentage basis, even though the verified data does not identify a fresh trigger. The move also means Bharat Parenterals Share Price Today finished closer to the session high than the session low, which is useful context for Bharat Parenterals Share Price Live tracking on Univest. The intraday range also shows that buyers were willing to absorb supply after the open, and the closing level near the upper half of the day’s band adds to the importance of the move in short-term market tracking. For investors scanning Bharat Parenterals Share Price today, the session behavior is more informative than the headline gain alone because it shows how the stock was priced through the day rather than only at the close.
The opening level of Rs 1,600 was already above the previous close, which indicates the stock started the session with positive sentiment intact. From there, the share price extended further during the day and reached Rs 1,745.95 before easing to the final close of Rs 1,710. That sequence matters because it suggests the move was not limited to a brief spike; instead, the price action stayed elevated for most of the session. For Bharat Parenterals Share Price Today, such positioning is often the first detail market participants look at when separating a routine uptick from a stronger trading day.
Bharat Parenterals Ltd. (BPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,059.26 crore |
| P/B Ratio | 3.42x |
| ROE | -8.36% |
| ROCE | -1.82% |
| EPS | Rs -22.35 |
| Book Value Per Share | Rs 462.38 |
| Dividend Yield | 0.06% |
Bharat Parenterals Ltd. (BPLPHARMA) fundamental metrics show P/B 3.42x, ROE -8.36%, ROCE -1.82%. These figures provide context only and are not a buy or sell signal.
Bharat Parenterals Ltd. has a market capitalisation of Rs 1059.26 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -8.36% and ROCE of -1.82%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs -22.35, book value per share of Rs 462.38, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.58x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 3.42x |
| Benchmark Median P/B | 2.95x |
| Company ROE | -8.36% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | -1.82% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 1,059.26 crore |
| Benchmark Median Market Cap | Rs 804.62 crore |
Bharat Parenterals Ltd. (BPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bharat Parenterals Ltd. (BPLPHARMA) has a ROE of -8.36%, which is below the benchmark median of 11.7%, a difference of -171.45%. Bharat Parenterals Ltd. (BPLPHARMA) has a ROCE of -1.82%, which is below the benchmark median of 13.61%, a difference of -113.37%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,47,475.97 | 36.76 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,54,763.56 | 87.25 | 14.45 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,423.19 | 86.07 | 20.91 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,16,658.07 | 26.08 | 4.37 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,484.47 | 33.65 | 3.23 | 11.83 | 16 |
Its ROE of -8.36% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at -1.82% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Bharat Parenterals Ltd. (BPLPHARMA) has a market capitalisation of Rs 1,059.26 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Bharat Parenterals
- Bharat Parenterals Share Price rose 8.28% today to Rs 1,710, after closing at Rs 1,579.25 in the previous session.
- The stock’s market capitalisation is Rs 1,059.26 crore, which places it above the same-industry median market cap of Rs 804.62 crore.
- P/B stands at 3.42 versus the industry median of 2.95 and average of 4.37, giving a clear valuation benchmark.
- ROE is -8.36% and ROCE is -1.82%, so Bharat Parenterals Fundamental Analysis still needs to be read carefully.
- The stock traded between Rs 1,590.05 and Rs 1,745.95 today, which keeps Bharat Parenterals Share Price Today in focus on Univest.
About Bharat Parenterals Ltd.
Bharat Parenterals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s presence in this segment places Bharat Parenterals Share Price inside a business area that typically includes formulation, drug development, manufacturing and related pharmaceutical activities. The supplied data does not break out revenue mix, product lines or segment contributions, so the company overview here stays limited to the verified sector and industry classification.
For readers following Bharat Parenterals Stock News, the key point is that the company is positioned within a broad healthcare ecosystem where listed peers range from value-oriented names to higher-multiple specialty pharma businesses. That makes Bharat Parenterals Share Price Today relevant not only as a market move, but also as a case study in how smaller healthcare companies are valued against a diverse listed peer group. Univest keeps the company page updated so users can follow Bharat Parenterals Share Price alongside the latest market context. The available data also shows a book value base and a low dividend yield, which are useful reference points for investors comparing the stock with other listed pharmaceutical names in the same industry. Even so, the day’s main story remains the price rise itself rather than any company-specific disclosure.
Track Bharat Parenterals Share Price on Univest
Use Bharat Parenterals Ltd. (BPLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Bharat Parenterals Share Price on Univest for live price updates, market cap, valuation ratios, peer comparison, sector context and the latest stock news. The platform also helps users review Bharat Parenterals Stock Analysis, Bharat Parenterals Fundamental Analysis and Bharat Parenterals Share Price Update in one place. For ongoing monitoring, Univest combines company data with useful market context so readers can keep Bharat Parenterals Share Price Today in view without searching across multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Bharat Parenterals Share Price rising today?
Ans. Bharat Parenterals Share Price rose 8.28% today to Rs 1,710. The supplied data confirms the price move, but it does not establish a company-specific catalyst for the rise. The previous close was Rs 1,579.25.
What is Bharat Parenterals Share Price today?
Ans. Bharat Parenterals Share Price today is Rs 1,710. It moved up by Rs 130.75 from the previous close of Rs 1,579.25, making it a notable stock news event. The previous close was Rs 1,579.25.
What is Bharat Parenterals market cap?
Ans. Bharat Parenterals has a market capitalisation of Rs 1,059.26 crore. That places it above the same-industry median market cap of Rs 804.62 crore in the supplied healthcare benchmark. The company operates in the Healthcare sector.
What does Bharat Parenterals P/B ratio show?
Ans. Bharat Parenterals has a P/B ratio of 3.42. That is above the industry median of 2.95 and below the industry average of 4.37 in the supplied peer benchmark. Its P/B ratio is 3.42x.
How does Bharat Parenterals compare with healthcare peers?
Ans. Bharat Parenterals is much smaller than Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals. It also has lower profitability metrics than the supplied peers, all of which show positive ROE and ROCE.
Should investors track Bharat Parenterals Share Price on Univest?
Ans. Bharat Parenterals Share Price can be tracked on Univest for live price, valuation, peer comparison and sector context. The platform presents the data together so readers can follow Bharat Parenterals Share Price Today clearly.
Recent Articles

Piramal Finance (PIRAMALFIN) Share Price Falls 2.25% Today
25 September 2026

Repro India Ltd. (REPRO): Repro India Share Price Near 52-Week Low as REPRO Falls 5.48%
25 September 2026

Aerpace Industries Ltd. Hits Upper Circuit on BSE, 25 September 2026
25 September 2026

Lloyds Engineering Works Ltd. (LLOYDSENGG): Lloyds Engineering Works Share Price Rises 5.40% Today
25 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Piramal Finance (PIRAMALFIN) Share Price Falls 2.25% Today
Repro India Ltd. (REPRO): Repro India Share Price Near 52-Week Low as REPRO Falls 5.48%
Aerpace Industries Ltd. Hits Upper Circuit on BSE, 25 September 2026
Lloyds Engineering Works Ltd. (LLOYDSENGG): Lloyds Engineering Works Share Price Rises 5.40% Today
Steelcast Ltd. (STEELCAS) Share Price Near 52-Week High After 4.89% Rise
Popular this week
Jindal Worldwide (JINDWORLD) Share Price Falls 6.56% to Rs 46; What the Stock News Shows

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





